Jianqiang Wu MD, PhD

Jianqiang Wu MD, PhD
Res InstructorCollege of MedicineJianqiang.Wu@cchmc.org
TCHRF Rm S7.224 3333 Burnet Avenue Cincinnati OH 45229
Phone:(513) 363-0955Fax: (513) 803-0783
  • Translational Therapeutics

Research Description

Dr. Wu's specializes in preclinical therapeutic trials on neurofibroma; cancer stem cell(s) in neurofibroma

Current Publications

  • Wu J, Patmore DM, Jousma E, Eaves DW, Breving K, Patel AV, Schwartz EB, Fuchs JR, Cripe TP, Stemmer-Rachamimov AO, Ratner NEGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.Oncogene 33 173-80 1/9/2014
  • Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N, Jessen WJ, Miller SJ, Jousma E, Wu JMEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.J Clin Invest 123 340-7 1/2/2013
  • Prada CE, Jousma E, Rizvi TA, Wu J, Dunn RS, Mayes DA, Cancelas JA, Dombi E, Kim MO, West BL, Bollag G, Ratner NNeurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.Acta Neuropathol 125 159-68 1/1/2013
  • Patmore DM, Welch S, Fulkerson PC, Wu J, Choi K, Eaves D, Kordich JJ, Collins MH, Cripe TP, Ratner NIn vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.Cancer Res 72 5317-27 10/15/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu